Webinar recap: Implementing Devyser BRCA to evaluate hereditary cancer risk
Hereditary cancers, particularly breast and ovarian cancers, pose a significant risk for many...
.png)
News | January 28, 2025
Devyser wins tender in Italy for its cystic fibrosis NGS test worth up to 5.4 million SEK
Find out more
.png)
.png)
.png)
.png)
.png)